Contracts › 75F40125F80163
75F40125F80163: Study Services in Support of the Risk Evaluation and Mitigation Strategy (REMS)
Awarded to The Mitre Corporation by Food and Drug Administration (FDA).
$1.4Mobligated
$1.4Mpotential value
14 December 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125F80163 |
|---|---|
| Vehicle | 75FCMC23D0004 |
| Awardee | The Mitre Corporation |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | R425 Support- Professional: Engineering/Technical |
| Place of performance | MD |
| Period of performance | 08 September 2025 to 14 December 2026 |
| Potential end | 14 December 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record